Taylor Wessing advises PanOpSys Limited on a $5.25 million Series A funding with Quester

The venture capital group at European law firm, Taylor Wessing, has advised PanOpSys Limited, a medical diagnostics company focusing on rapid quantitative detection of disease markers, on the raising of $5.25 million following a Series A funding from Quester.

Quester is a market leader in identifying robust technologies at an early stage and PanOpSys is the latest in a series of investments in which Quester has provided Series A funding to spin-out companies, with another recent investment being Perpetuum, on which Taylor Wessing also advised.  PanOpSys Limited intends this funding to go towards implementing its commercialisation plans. 

The Taylor Wessing team advising PanOpSys comprised Simon Walker, Adrian Rainey and Sian Griffiths (corporate), Darren Bezzina (intellectual property) and Camilla Marriott (employment).

Olswang advised investor Quester.

Ends

Notes to editors

For more information please contact Sheena Lee at Taylor Wessing.

Tel: +44(0)20 7300 4930

About Taylor Wessing's Life Sciences & Healthcare Group

Taylor Wessing's market-leading Life Sciences & Healthcare Group provides a top quality, multi-disciplinary service.  The Group combines Taylor Wessing's top-rated intellectual property and venture capital lawyers with specialists from our highly acclaimed international corporate, corporate finance, employment and real estate practices.  We advise life sciences and healthcare businesses, those who fund them and those who work for them.

For more information about Taylor Wessing's Life Sciences & Healthcare Group, please click here.

For any legal enquiries, please contact Daniel Pavin or your usual contact at Taylor Wessing.  For any marketing and business development enquiries, please contact Sharon Philbey.